Biomea Fusion, Inc.

NASDAQ:BMEA

Biotechnology

Healthcare
$0.74 -2.50%

-$0.03 today

Market cap
$53.18M
Beta
-0.33
P/E (TTM)
-1.9
EPS (TTM)
-$0.62
52W Low $0.87High $2.99

Volume 3.50M

Average 1.52M

Returns on capital

Biomea Fusion, Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

-209.1%

avg 708.0%

ROIC

-166.2%

avg 729.7%

ROA

-105.5%

avg -126.2%

Analysis

ROA is currently the strongest return metric at -105.5% versus its period average of -126.2%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Michael J. Hitchcock

Interim Chief Executive Officer & DirectorUSD 867.94K76——

Ramses Erdtmann

Co-Founder, President, Chief Operating Officer & DirectorUSD 636.49K63——

Caroline Perez- Dupont

Senior Vice President of Legal————

Heow Tan

Chief Technology & Quality Officer—67——

Stephan Morris

Chief Development Officer————

Ravi Upasani

Executive Vice President of Intellectual Property————

Thorsten Kirschberg

Executive Vice President of Research—56——

Compensation is shown in the reported currency; data updated Oct 3, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

4

$196,731.00

Sells

0

$0.00

Net Transaction Value

+$196,731.00

Net buying

Most Active

Erdtmann Rainer M

3 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Dec 11, 25

Erdtmann Rainer M

Direct

Buy$43K
Dec 2, 25

Hitchcock Michael J.M.

Direct

Buy$99.2K
Dec 1, 25

Erdtmann Rainer M

Direct

Buy$10.5K
Nov 28, 25

Erdtmann Rainer M

Direct

Buy$44.1K

Summary

Insiders reported 4 buys worth $196,731.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $196,731.00. Erdtmann Rainer M was the most active insider with 3 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/AN/A
N/A1 analysts
RevenueN/AN/AN/A
N/A3 analysts
Net IncomeN/AN/AN/A
N/A3 analysts
EBITN/AN/AN/A
N/A3 analysts

Analysis

Analysis will appear once historical growth or forward estimates are available for this company.

Competitors

Who does Biomea Fusion, Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about BMEA's management, answered from reported figures.

Who manages BMEA?

Biomea Fusion, Inc. (BMEA) lists 7 active executives. The top listed executive is Caroline Perez- Dupont, Senior Vice President of Legal.

Are BMEA insiders buying or selling?

Recent insider activity shows net buying of $49.11M.